Omalizumab reduces cysteinyl leukotriene and 9α,11β-prostaglandin F2 overproduction in aspirin-exacerbated respiratory disease

J Allergy Clin Immunol. 2016 May;137(5):1585-1587.e4. doi: 10.1016/j.jaci.2015.09.034. Epub 2015 Nov 11.

¹ Clinical Research Center for Allergy and Rheumatology, Sagamihara National Hospital, Sagamihara, Kanagawa, Japan; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.
² Clinical Research Center for Allergy and Rheumatology, Sagamihara National Hospital, Sagamihara, Kanagawa, Japan.
³ Translational Research Informatics Center, Foundation for Biomedical Research and Innovation, Kobe, Japan.
⁴ Clinical Research Center for Allergy and Rheumatology, Sagamihara National Hospital, Sagamihara, Kanagawa, Japan; Department of Allergy and Clinical Immunology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
⁵ Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.
⁶ Clinical Research Center for Allergy and Rheumatology, Sagamihara National Hospital, Sagamihara, Kanagawa, Japan. Electronic address: m-taniguchi@sagamihara-hosp.gr.jp.

No abstract available

Publication types